You are here

  • Home
  • Archive
  • Volume 16, Issue 2
  • Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study

Citation Tools

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Matthews DR
Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study
BMJ Evidence-Based Medicine 2011;16:45-46.